Document is current

Any future updates will be listed below

Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo

Crossref DOI link: https://doi.org/10.1186/s12885-023-11135-3

Published Online: 2023-07-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark